Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Vital KSK Holdings, Inc. ( (JP:3151) ) is now available.
Vital KSK Holdings, Inc. has revised its financial forecasts for Fiscal Year 2025, anticipating a decrease in net sales and operating profit due to lower sales in its core pharmaceutical wholesale business and increased research and development expenses. However, the company expects a significant increase in ordinary income from non-operating income, driven by investment returns from the MIJ Healthcare No. 1 Investment Limited Partnership.
The most recent analyst rating on (JP:3151) stock is a Hold with a Yen1340.00 price target. To see the full list of analyst forecasts on Vital KSK Holdings, Inc. stock, see the JP:3151 Stock Forecast page.
More about Vital KSK Holdings, Inc.
Vital KSK Holdings, Inc. operates in the pharmaceutical industry, primarily focusing on pharmaceutical wholesale services. The company is affected by market dynamics such as drug price revisions and competitive bidding, which influence its sales and profitability.
Average Trading Volume: 126,583
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen56.87B
See more insights into 3151 stock on TipRanks’ Stock Analysis page.